Barclays Issues Pessimistic Forecast for Sapiens International (NASDAQ:SPNS) Stock Price

Sapiens International (NASDAQ:SPNSGet Free Report) had its target price reduced by equities researchers at Barclays from $38.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “underweight” rating on the technology company’s stock. Barclays‘s price objective would indicate a potential upside of 5.15% from the stock’s previous close.

A number of other analysts have also recently commented on SPNS. StockNews.com upgraded shares of Sapiens International from a “buy” rating to a “strong-buy” rating in a research note on Monday. The Goldman Sachs Group upped their price target on shares of Sapiens International from $38.00 to $43.00 and gave the company a “buy” rating in a research note on Friday, August 2nd. Finally, Needham & Company LLC dropped their price target on shares of Sapiens International from $44.00 to $35.00 and set a “buy” rating on the stock in a research note on Tuesday.

Read Our Latest Research Report on Sapiens International

Sapiens International Stock Up 1.5 %

SPNS opened at $28.53 on Tuesday. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.04. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 22.46 and a beta of 1.25. Sapiens International has a twelve month low of $25.00 and a twelve month high of $41.22. The company’s 50-day moving average price is $36.07 and its two-hundred day moving average price is $35.38.

Sapiens International (NASDAQ:SPNSGet Free Report) last released its earnings results on Monday, November 11th. The technology company reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). The company had revenue of $137.00 million during the quarter, compared to analysts’ expectations of $140.10 million. Sapiens International had a net margin of 13.23% and a return on equity of 17.81%. The firm’s revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.32 earnings per share. As a group, equities analysts expect that Sapiens International will post 1.42 earnings per share for the current year.

Institutional Trading of Sapiens International

Hedge funds and other institutional investors have recently bought and sold shares of the company. Summit Securities Group LLC bought a new stake in Sapiens International during the 2nd quarter worth approximately $34,000. Financial Management Professionals Inc. increased its holdings in Sapiens International by 57.9% during the 3rd quarter. Financial Management Professionals Inc. now owns 1,945 shares of the technology company’s stock worth $72,000 after acquiring an additional 713 shares during the period. Morgan Dempsey Capital Management LLC increased its holdings in Sapiens International by 9.5% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,206 shares of the technology company’s stock worth $143,000 after acquiring an additional 365 shares during the period. Lazard Asset Management LLC bought a new stake in Sapiens International during the 1st quarter worth approximately $192,000. Finally, MQS Management LLC bought a new stake in Sapiens International during the 3rd quarter worth approximately $230,000. Institutional investors own 30.73% of the company’s stock.

About Sapiens International

(Get Free Report)

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.

Featured Articles

Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.